Health & Fitness
Health and Fitness
Health and Fitness
Thu, October 13, 2011
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
[ Thu, Oct 13th 2011
] - Market Wire
Los datos presentados durante el 5 Congreso trienal organizado conjuntamente por ECTRIMS y ACTRIMS demuestran el compromiso y l
WESTON, Massachussets--([ BUSINESS WIRE ])--Hoy [ Biogen Idec ] (NASDAQ: BIIB) ha anunciado que una slida seleccin de datos de la franquicia MS (esclerosis mltiple) de la empresa se presentar en 48 psters y cinco presentaciones de plataforma durante el 5 Congreso trienal conjunto de los comit©s europeos y americanos para el tratamiento e investigacin de la esclerosis mltiple (ECTRIMS y ACTRIMS) en msterdam (Holanda), del 19 al 22 de octubre.
El comunicado en el idioma original, es la versin oficial y autorizada del mismo. La traduccin es solamente un medio de ayuda ydeber sercomparada con el texto en idioma original, que es la nica versin del texto que tendr validez legal.
Contributing Sources
